In sample set I, the tryptic peptides of synaptotagmin-1 were significantly higher in patients with MCI due to Alzheimer’s disease compared with patients with dementia due to Alzheimer’s disease (Fig. 1a, b). Here, SYT1 is linked to Alzheimer disease.